GeneDx Holdings Corp. (WGS): who owns it and who trades it
As of Nov 16, 2026, WGS insiders reported 105 open-market sales worth $21.5M and 34 purchases worth $107M in the last 12 months, with 2% of the sale value made under pre-set 10b5-1 plans. The largest seller was Katherine Stueland (CEO), with $11.2M. 4 of the 50 famous funds we follow held it at their last quarter end.
Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.
At a glance
Who is buying and selling GeneDx Holdings
From the latest filingsOverall: about as much buying as selling. Insiders mostly sold. Funds and famous investors were close to even.
Each group counts equally in the meter, by the number of buyers and sellers, not dollars. Insider sales under pre-set 10b5-1 plans are left out of it. From SEC, House and Senate filings; not advice.
Who owns WGS
222 funds and institutions reported WGS shares worth $2.2B at the end of Q2 2026. Some shares are counted by more than one filer, or lent out and counted twice, so the total can pass 100%. The largest holder is Corvex Management LP with 16.1%.
Funds and institutions (13F) about 100%Everyone else 0%
10 largest owners, by share of the company
Top 20 owners
| Owner | Shares | % of company | Value | Change since Q1 2026 |
|---|---|---|---|---|
| Corvex Management LP | 4.78M | 16.12% | $328M | +48% |
| Casdin Capital, LLC | 3.71M | 12.49% | $254M | +23% |
| BlackRock, Inc. | 1.71M | 5.75% | $117M | +10% |
| Goldman Sachs Group Inc | 1.67M | 5.62% | $115M | +25% |
| ARK Investment Management LLC | 1.61M | 5.42% | $111M | +22% |
| William Blair Investment Management, LLC | 1.40M | 4.72% | $96.2M | +81% |
| Morgan Stanley | 988,297 | 3.33% | $67.8M | +86% |
| Vanguard Capital Management LLC | 879,003 | 2.96% | $60.3M | +2% |
| Citadel Advisors LLC | 865,462 | 2.92% | $59.4M | +34% |
| First Light Asset Management, LLC | 783,923 | 2.64% | $53.8M | +223% |
| Deep Track Capital, LP | 700,000 | 2.36% | $48.1M | – |
| Amova Asset Management Americas, Inc. | 666,581 | 2.25% | $45.7M | +4% |
| Sumitomo Mitsui Trust Group, Inc. | 666,581 | 2.25% | $45.8M | +5% |
| Assenagon Asset Management S.A. | 606,866 | 2.04% | $41.7M | +538% |
| Zweig-DiMenna Associates LLC | 571,950 | 1.93% | $39.3M | -17% |
| Geode Capital Management, LLC | 552,125 | 1.86% | $37.9M | +1% |
| State Street Corp | 527,815 | 1.78% | $36.2M | +12% |
| Gagnon Securities LLC | 524,865 | 1.77% | $36M | +73% |
| Aberdeen Group plc | 457,201 | 1.54% | $31.4M | +99% |
| Wellington Management Group LLP | 347,927 | 1.17% | $23.9M | +2% |
From the SEC 13F data sets: every fund manager with over $100M must report its US stock holdings every 3 months, up to 45 days after the quarter ends. Owners are shown as they file, so one group (for example Vanguard) can appear under several names. Individuals, most insiders and smaller funds do not file 13F reports.
Insider trades
In the last 12 months, WGS insiders reported $107M of open-market purchases and $21.5M of sales. 2% of the sale value was under a 10b5-1 plan, a schedule set up in advance.
Purchases and sales by month
Latest trades
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Sep 16, 2026 | Katherine Stueland | CEO | Sale | 4,141 | $98.27 | $407K | Form 4 |
| Sep 16, 2026 | Katherine Stueland | CEO | Sale | 1,525 | $96.90 | $148K | Form 4 |
| Sep 16, 2026 | Katherine Stueland | CEO | Sale | 148 | $95.41 | $14.1K | Form 4 |
| Sep 16, 2026 | Katherine Stueland | CEO | Sale | 1,648 | $94.26 | $155K | Form 4 |
| Sep 16, 2026 | Katherine Stueland | CEO | Sale | 3,039 | $99.00 | $301K | Form 4 |
| Sep 16, 2026 | Kevin Feeley | CFO | Sale | 586 | $94.26 | $55.2K | Form 4 |
| Sep 16, 2026 | Kevin Feeley | CFO | Sale | 1,079 | $99.00 | $107K | Form 4 |
| Sep 16, 2026 | Kevin Feeley | CFO | Sale | 541 | $96.90 | $52.4K | Form 4 |
| Sep 16, 2026 | Kevin Feeley | CFO | Sale | 1,470 | $98.27 | $144K | Form 4 |
| Sep 16, 2026 | Kevin Feeley | CFO | Sale | 52 | $95.41 | $5K | Form 4 |
| Sep 9, 2026 | Katherine Stueland | CEO | Sale | 3,692 | $84.22 | $311K | Form 4 |
| Sep 9, 2026 | Kevin Feeley | CFO | Sale | 1,285 | $84.22 | $108K | Form 4 |
| Sep 1, 2026 | Kevin Feeley | CFO | Sale | 372 | $83.84 | $31.2K | Form 4 |
| Jun 16, 2026 | Kevin Feeley | CFO | Sale | 2,106 | $60.83 | $128K | Form 4 |
| Jun 16, 2026 | Kevin Feeley | CFO | Sale | 863 | $61.50 | $53.1K | Form 4 |
| Jun 16, 2026 | Kevin Feeley | CFO | Sale | 760 | $59.75 | $45.4K | Form 4 |
| Jun 16, 2026 | Katherine Stueland | CEO | Sale | 5,932 | $60.83 | $361K | Form 4 |
| Jun 16, 2026 | Katherine Stueland | CEO | Sale | 2,140 | $59.75 | $128K | Form 4 |
| Jun 16, 2026 | Katherine Stueland | CEO | Sale | 2,429 | $61.50 | $149K | Form 4 |
| Jun 9, 2026 | Kevin Feeley | CFO | Sale | 1,266 | $53.77 | $68.1K | Form 4 |
| Jun 9, 2026 | Katherine Stueland | CEO | Sale | 3,639 | $53.77 | $196K | Form 4 |
| Jun 5, 2026 | Eli Casdin +3 | Director | Purchase | 50,000 | $52.86 | $2.6M | Form 4 |
| Jun 4, 2026 | Eli Casdin +3 | Director | Purchase | 150,000 | $56.44 | $8.5M | Form 4 |
| Jun 1, 2026 | Kevin Feeley | CFO | Sale | 369 | $51.74 | $19.1K | Form 4 |
| May 20, 2026 | Casdin Partners Master Fund, L.P. +3 | Director | Purchase | 140,000 | $43.81 | $6.1M | Form 4 |
| May 19, 2026 | Casdin Partners Master Fund, L.P. +3 | Director | Purchase | 185,000 | $42.60 | $7.9M | Form 4 |
| May 18, 2026 | Casdin Partners Master Fund, L.P. +3 | Director | Purchase | 175,000 | $42.55 | $7.4M | Form 4 |
| May 15, 2026 | Keith A. Meister +1 | Director | Purchase | 18,865 | $39.83 | $751K | Form 4 |
| May 15, 2026 | Keith A. Meister +1 | Director | Purchase | 27,408 | $38.28 | $1M | Form 4 |
| May 14, 2026 | Keith A. Meister +1 | Director | Purchase | 51,893 | $39.92 | $2.1M | Form 4 |
| May 14, 2026 | Keith A. Meister +1 | Director | Purchase | 88,107 | $39.08 | $3.4M | Form 4 |
| May 13, 2026 | Keith A. Meister +1 | Director | Purchase | 70,926 | $39.45 | $2.8M | Form 4 |
| May 13, 2026 | Keith A. Meister +1 | Director | Purchase | 94,074 | $38.82 | $3.7M | Form 4 |
| May 11, 2026 | Keith A. Meister +1 | Director | Purchase | 246,734 | $38.91 | $9.6M | Form 4 |
| May 11, 2026 | Keith A. Meister +1 | Director | Purchase | 532 | $40.35 | $21.5K | Form 4 |
| May 11, 2026 | Keith A. Meister +1 | Director | Purchase | 252,734 | $39.65 | $10M | Form 4 |
| May 8, 2026 | Keith A. Meister +1 | Director | Purchase | 15,745 | $38.00 | $598K | Form 4 |
| May 8, 2026 | Keith A. Meister +1 | Director | Purchase | 3,396 | $38.70 | $131K | Form 4 |
| May 8, 2026 | Keith A. Meister +1 | Director | Purchase | 79,144 | $40.67 | $3.2M | Form 4 |
| May 8, 2026 | Keith A. Meister +1 | Director | Purchase | 73,104 | $41.15 | $3M | Form 4 |
| May 7, 2026 | Keith A. Meister +1 | Director | Purchase | 56,630 | $40.46 | $2.3M | Form 4 |
| May 7, 2026 | Keith A. Meister +1 | Director | Purchase | 94,356 | $39.39 | $3.7M | Form 4 |
| May 7, 2026 | Keith A. Meister +1 | Director | Purchase | 128,181 | $35.46 | $4.5M | Form 4 |
| May 7, 2026 | Keith A. Meister +1 | Director | Purchase | 14,786 | $36.33 | $537K | Form 4 |
| May 7, 2026 | Keith A. Meister +1 | Director | Purchase | 123,393 | $37.60 | $4.6M | Form 4 |
| May 7, 2026 | Keith A. Meister +1 | Director | Purchase | 116,412 | $38.46 | $4.5M | Form 4 |
| Apr 29, 2026 | Katherine Stueland | CEO | Sale | 2,154 | $65.20 | $140K | Form 4 |
| Apr 29, 2026 | Katherine Stueland | CEO | Sale | 18 | $64.12 | $1.2K | Form 4 |
| Apr 29, 2026 | Kevin Feeley | CFO | Sale | 392 | $65.19 | $25.6K | Form 4 |
| Mar 26, 2026 | Kevin Feeley | CFO | Sale | 1,857 | $65.21 | $121K | Form 4 |
| Mar 26, 2026 | Kevin Feeley | CFO | Sale | 995 | $64.60 | $64.3K | Form 4 |
| Mar 26, 2026 | Kevin Feeley | CFO | Sale | 2,520 | $63.28 | $159K | Form 4 |
| Mar 26, 2026 | Kevin Feeley | CFO | Sale | 961 | $62.33 | $59.9K | Form 4 |
| Mar 26, 2026 | Kevin Feeley | CFO | Sale | 2,485 | $61.29 | $152K | Form 4 |
| Mar 26, 2026 | Katherine Stueland | CEO | Sale | 5,117 | $62.33 | $319K | Form 4 |
| Mar 26, 2026 | Katherine Stueland | CEO | Sale | 13,229 | $61.29 | $811K | Form 4 |
| Mar 26, 2026 | Katherine Stueland | CEO | Sale | 9,883 | $65.21 | $644K | Form 4 |
| Mar 26, 2026 | Katherine Stueland | CEO | Sale | 13,412 | $63.28 | $849K | Form 4 |
| Mar 26, 2026 | Katherine Stueland | CEO | Sale | 5,292 | $64.60 | $342K | Form 4 |
| Mar 16, 2026 | Katherine Stueland | CEO | Sale | 772 | $77.94 | $60.2K | Form 4 |
| Mar 16, 2026 | Katherine Stueland | CEO | Sale | 9,229 | $77.05 | $711K | Form 4 |
| Mar 16, 2026 | Katherine Stueland | CEO | Sale | 7,178 | $76.35 | $548K | Form 4 |
| Mar 16, 2026 | Kevin Feeley | CFO | Sale | 257 | $77.94 | $20K | Form 4 |
| Mar 16, 2026 | Kevin Feeley | CFO | Sale | 3,065 | $77.05 | $236K | Form 4 |
| Mar 16, 2026 | Kevin Feeley | CFO | Sale | 2,384 | $76.35 | $182K | Form 4 |
| Mar 9, 2026 | Kevin Feeley | CFO | Sale | 1,280 | $86.75 | $111K | Form 4 |
| Mar 9, 2026 | Katherine Stueland | CEO | Sale | 3,678 | $86.75 | $319K | Form 4 |
| Mar 5, 2026 | Keith A. Meister +1 | Director | Purchase | 29,236 | $82.06 | $2.4M | Form 4 |
| Mar 5, 2026 | Keith A. Meister +1 | Director | Purchase | 304 | $77.96 | $23.7K | Form 4 |
| Mar 5, 2026 | Keith A. Meister +1 | Director | Purchase | 1,971 | $78.91 | $156K | Form 4 |
| Mar 5, 2026 | Keith A. Meister +1 | Director | Purchase | 47,623 | $80.55 | $3.8M | Form 4 |
| Mar 5, 2026 | Keith A. Meister +1 | Director | Purchase | 60,892 | $81.37 | $5M | Form 4 |
| Mar 4, 2026 | Kevin Feeley | CFO | Sale | 2,543 | $78.61 | $200K | Form 4 |
| Mar 4, 2026 | Kevin Feeley | CFO | Sale | 2,220 | $79.25 | $176K | Form 4 |
| Mar 4, 2026 | Kevin Feeley | CFO | Sale | 1,424 | $77.63 | $111K | Form 4 |
| Mar 4, 2026 | Katherine Stueland | CEO | Sale | 5,861 | $77.63 | $455K | Form 4 |
| Mar 4, 2026 | Katherine Stueland | CEO | Sale | 10,465 | $78.61 | $823K | Form 4 |
| Mar 4, 2026 | Katherine Stueland | CEO | Sale | 9,133 | $79.25 | $724K | Form 4 |
| Mar 3, 2026 | Keith A. Meister +1 | Director | Purchase | 19,686 | $70.34 | $1.4M | Form 4 |
| Mar 3, 2026 | Keith A. Meister +1 | Director | Purchase | 8,439 | $71.48 | $603K | Form 4 |
| Mar 3, 2026 | Keith A. Meister +1 | Director | Purchase | 200 | $72.00 | $14.4K | Form 4 |
| Mar 3, 2026 | Keith A. Meister +1 | Director | Purchase | 921 | $75.66 | $69.7K | Form 4 |
| Mar 3, 2026 | Keith A. Meister +1 | Director | Purchase | 249 | $75.99 | $18.9K | Form 4 |
| Mar 2, 2026 | Kevin Feeley | CFO | Sale | 287 | $77.52 | $22.2K | Form 4 |
| Feb 4, 2026 | Bryan Dechairo | Chief Operating Officer | Sale plan | 100 | $91.92 | $9.2K | Form 4 |
| Feb 4, 2026 | Bryan Dechairo | Chief Operating Officer | Sale plan | 1,425 | $83.83 | $119K | Form 4 |
| Feb 4, 2026 | Bryan Dechairo | Chief Operating Officer | Sale plan | 779 | $83.04 | $64.7K | Form 4 |
| Feb 4, 2026 | Bryan Dechairo | Chief Operating Officer | Sale plan | 623 | $86.35 | $53.8K | Form 4 |
| Feb 4, 2026 | Bryan Dechairo | Chief Operating Officer | Sale plan | 1,572 | $87.66 | $138K | Form 4 |
| Feb 4, 2026 | Bryan Dechairo | Chief Operating Officer | Sale plan | 328 | $88.66 | $29.1K | Form 4 |
| Feb 4, 2026 | Bryan Dechairo | Chief Operating Officer | Sale plan | 100 | $90.45 | $9K | Form 4 |
| Feb 4, 2026 | Bryan Dechairo | Chief Operating Officer | Sale plan | 1,034 | $84.93 | $87.8K | Form 4 |
| Feb 2, 2026 | Bryan Dechairo | Chief Operating Officer | Sale | 1,166 | $100.31 | $117K | Form 4 |
| Feb 2, 2026 | Bryan Dechairo | Chief Operating Officer | Sale | 492 | $98.61 | $48.5K | Form 4 |
| Feb 2, 2026 | Bryan Dechairo | Chief Operating Officer | Sale | 1,662 | $99.40 | $165K | Form 4 |
| Feb 2, 2026 | Bryan Dechairo | Chief Operating Officer | Sale | 93 | $96.77 | $9K | Form 4 |
| Jan 29, 2026 | Kevin Feeley | CFO | Sale | 2 | $92.06 | $184 | Form 4 |
| Jan 29, 2026 | Kevin Feeley | CFO | Sale | 315 | $94.00 | $29.6K | Form 4 |
| Jan 29, 2026 | Katherine Stueland | CEO | Sale | 1,653 | $94.00 | $155K | Form 4 |
| Dec 16, 2025 | Kevin Feeley | CFO | Sale | 366 | $140.08 | $51.3K | Form 4 |
Latest 100 of 139 trades in the last 12 months.
Insiders by value traded
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| Keith A. Meister | Director, 10% owner | $74M | – | May 15, 2026 |
| Casdin Partners Master Fund, L.P. | Director, 10% owner | $21.5M | – | May 20, 2026 |
| Katherine Stueland | CHIEF EXECUTIVE OFFICER, Director | – | $11.2M | Sep 16, 2026 |
| Eli Casdin | Director, 10% owner | $11.1M | – | Jun 5, 2026 |
| Joshua Ruch | Director | – | $6.1M | Nov 24, 2025 |
| Kevin Feeley | CHIEF FINANCIAL OFFICER | – | $3.3M | Sep 16, 2026 |
| Bryan Dechairo | Chief Operating Officer | – | $851K | Feb 4, 2026 |
What this data shows, and what it doesn't
- Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
- Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
- "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
- Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
- Filings are self-reported and can be amended. Each trade links to its original filing. Methodology
WGS short interest
Very high short interest. 22.0% of WGS shares are sold short: about 1 share in 5. Over the last 12 reports the number of shares short went up 33%.
As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.
As of Oct 30, 2026, 6.55M WGS shares were sold short, 22.0% of the shares outstanding, up 8.8% from the report before. At the average daily volume of 901,145 shares, buying them all back would take about 7.3 trading days (days to cover).
Shares short, % of all shares
Days to cover
Every report
| Settlement date | Shares short | % of shares | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|---|
| Oct 30, 2026 | 6.55M | 21.97% | +9% | 901,145 | 7.3 |
| Oct 15, 2026 | 6.02M | 20.19% | +7% | 689,838 | 8.7 |
| Sep 30, 2026 | 5.63M | 18.87% | -4% | 945,488 | 6.0 |
| Sep 15, 2026 | 5.88M | 19.73% | -2% | 486,859 | 12.1 |
| Aug 31, 2026 | 6.00M | 20.12% | -5% | 482,871 | 12.4 |
| Aug 14, 2026 | 6.29M | 21.09% | +8% | 984,437 | 6.4 |
| Jul 31, 2026 | 5.85M | 19.61% | +0% | 681,961 | 8.6 |
| Jul 15, 2026 | 5.83M | 19.64% | -2% | 691,655 | 8.4 |
| Jun 30, 2026 | 5.94M | 20.01% | -1% | 1.01M | 5.9 |
| Jun 15, 2026 | 6.01M | 20.25% | +31% | 1.22M | 4.9 |
| May 29, 2026 | 4.57M | 15.40% | -7% | 1.33M | 3.4 |
| May 15, 2026 | 4.93M | 16.61% | +17% | 2.94M | 1.7 |
Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks
GeneDx Holdings company events
GeneDx Holdings filed 8 reports on Form 8-K in the last 12 months, 1 of them about an important change (leadership). The latest was on Nov 9, 2026.
- Nov 9, 2026ResultsReleased financial results. Filing
- Aug 3, 2026ResultsReleased financial results. Filing
- Jun 23, 2026VoteReported shareholder vote results. Filing
- Jun 16, 2026LeadershipGeneDx Holdings Corp. announced the appointment of Mark Gardner, age 60, in the role of President, which was effective on June 15, 2026. Filing
- May 4, 2026ResultsReleased financial results. Filing
- Mar 2, 2026AgreementGeneDx Holdings Corp. entered into a Loan Agreement, with Blackstone Alternative Credit Advisors LP and Blackstone Life Sciences Advisors L.L.C. (collectively, the “Blackstone Representative” and referred to herein as “Blackstone”), certain subsidiaries of the Company party thereto as Guarantors… Filing
- Feb 23, 2026ResultsReleased financial results. Filing
- Jan 12, 2026ResultsReleased financial results. Filing
From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week
GeneDx Holdings financials
Famous investors that hold WGS
4 of the 50 well-known investors we track reported holding WGS in their latest 13F filing. The largest position is Cathie Wood's, worth $138M.
Position size
All holders
| Fund | Quarter | Shares | Value | Of portfolio | Change |
|---|---|---|---|---|---|
| Cathie Wood · ARK Investment Management | Q3 2026 | 1.91M | $138M | 0.8% | +19% |
| Israel Englander · Millennium Management | Q3 2026 | 1.09M | $78.7M | 0.1% | +600% |
| Ken Griffin · Citadel Advisors | Q3 2026 | 668,709 | $48.3M | 0.0% | -23% |
| Paul Tudor Jones · Tudor Investment Corp | Q3 2026 | 85,829 | $6.2M | 0.0% | -21% |
From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.
5%+ stakes filed in the last 120 days
Anyone who owns more than 5% of a company must report it on Schedule 13D or 13G. 4 filings named WGS in the last 120 days.
| Filed | Holder | Form | Stake |
|---|---|---|---|
| Nov 13, 2026 | ARK Investment Management LLC | 13G/A | 6.4% |
| Nov 13, 2026 | ARK Investment Management LLC | 13G/A | 6.4% |
| Nov 6, 2026 | WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | 13G | 5.2% |
| Nov 6, 2026 | WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | 13G | 5.2% |
Questions about GeneDx Holdings Corp. (WGS) stock
Who owns the most WGS stock?
The largest reported owner of GeneDx Holdings Corp. (WGS) is Corvex Management LP, with 16.1% of the company. In total, 222 funds and institutions reported holding WGS at the end of Q2 2026, together about 100% of the shares. See the largest owners.
Are WGS insiders buying or selling?
In the last 12 months, WGS insiders reported 34 open-market purchases worth $107M and 105 sales worth $21.5M. The latest trade was on Sep 16, 2026. See every trade.
What is the short interest in WGS?
As of Oct 30, 2026, 6.55M WGS shares were sold short, 22.0% of the shares outstanding, up 8.8% from the report before. At the average daily volume of 901,145 shares, buying them all back would take about 7.3 trading days (days to cover). See the history.
Which famous investors hold WGS?
4 of the 50 well-known investors we track reported WGS in their latest 13F filing, including Cathie Wood, Israel Englander, Ken Griffin. The largest position is worth $138M. See all holders.
Executive pay
GeneDx Holdings's chief executive was paid a total of $13.5M for the year ended Dec 31, 2025, up 206% from $4.4M the year before. In the last 12 months, GeneDx Holdings's executives and directors bought $85.1M of stock on the open market and sold $21.5M.
From the pay versus performance table in the company's annual proxy statement (DEF 14A), as the company reported it. If the chief executive changed during the year, the company reports each person separately and this shows one of them.
Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.